Kajian klinikal Asma di Kentucky
7 kajian untuk Asma sedang mencari peserta di lokasi di Kentucky.
Teks kajian rasmi (Bahasa Inggeris)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Owensboro
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Owensboro
Mengambil pesertaFasa 3
Umur 12 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Louisville
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Owensboro
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07301255A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Allergy & Asthma Specialists, P.S.C., Owensboro
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07219173A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Owensboro
Mengambil pesertaFasa 2
Umur 4 hingga 11 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07525375Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Louisville
- Research Site, Louisville
Mengambil pesertaFasa 3
Umur 12 hingga 17 · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT06307665Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.